AAAAAA

   
Results: 1-8 |
Results: 8
Design of new mononucleotide prodrugs: Aryl (SATE) phosphotriester derivatives
Authors: Peyrottes, S Schlienger, N Beltran, T Lefebvre, I Pompon, A Gosselin, G Aubertin, AM Imbach, JL Perigaud, C
Citation: S. Peyrottes et al., Design of new mononucleotide prodrugs: Aryl (SATE) phosphotriester derivatives, NUCLEOS NUC, 20(4-7), 2001, pp. 315-321
Simultaneous HPLC analysis of hydrophobic prodrugs and their hydrophilic metabolites in biological media without sample preparation. Application to the biotransformation studies of pronucleotides derived from 5-fluorouracil
Authors: Coussot, G Lefebvre-Tournier, I Hollecker, L Gosselin, G Imbach, JL Pompon, A
Citation: G. Coussot et al., Simultaneous HPLC analysis of hydrophobic prodrugs and their hydrophilic metabolites in biological media without sample preparation. Application to the biotransformation studies of pronucleotides derived from 5-fluorouracil, NUCLEOS NUC, 20(4-7), 2001, pp. 855-858
Kinetics study of the biotransformation of an oligonucleotide prodrug in cells extract by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Authors: Morvan, F Bres, JC Lefebvre, I Vasseur, JJ Pompon, A Imbach, JL
Citation: F. Morvan et al., Kinetics study of the biotransformation of an oligonucleotide prodrug in cells extract by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, NUCLEOS NUC, 20(4-7), 2001, pp. 1159-1163
Cancer chemotherapy: A paclitaxel prodrug for ADEPT (antibody-directed enzyme prodrug therapy)
Authors: Schmidt, F Ungureanu, I Duval, R Pompon, A Monneret, C
Citation: F. Schmidt et al., Cancer chemotherapy: A paclitaxel prodrug for ADEPT (antibody-directed enzyme prodrug therapy), EUR J ORG C, (11), 2001, pp. 2129-2134
Kinetics study of the biotransformation of an oligonucleotide prodrug in cells extract by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry
Authors: Bres, JC Morvan, F Lefebvre, I Vasseur, JJ Pompon, A Imbach, JL
Citation: Jc. Bres et al., Kinetics study of the biotransformation of an oligonucleotide prodrug in cells extract by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry, J CHROMAT B, 753(1), 2001, pp. 123-130
Rational design of a new series of pronucleotide
Authors: Beltran, T Egron, D Pompon, A Lefebvre, I Perigaud, C Gosselin, G Aubertin, AM Imbach, JL
Citation: T. Beltran et al., Rational design of a new series of pronucleotide, BIOORG MED, 11(13), 2001, pp. 1775-1777
New bis(SATE) prodrug of AZT 5 '-monophosphate: In vitro anti-HIV activity, stability, and potential oral absorption
Authors: Shafiee, M Deferme, S Villard, AL Egron, D Gosselin, G Imbach, JL Lioux, T Pompon, A Varray, S Aubertin, AM Van den Mooter, G Kinget, R Perigaud, C Augustijns, P
Citation: M. Shafiee et al., New bis(SATE) prodrug of AZT 5 '-monophosphate: In vitro anti-HIV activity, stability, and potential oral absorption, J PHARM SCI, 90(4), 2001, pp. 448-463
Anti-HIV pronucleotides: Sate versus phenyl as a protecting grow of AZT phosphoramidate derivatives
Authors: Beltran, T Egron, D Lefebvre, I Perigaud, C Pompon, A Gosselin, G Aubertin, AM Imbach, JL
Citation: T. Beltran et al., Anti-HIV pronucleotides: Sate versus phenyl as a protecting grow of AZT phosphoramidate derivatives, NUCLEOS NUC, 18(4-5), 1999, pp. 973-975
Risultati: 1-8 |